XML 31 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
SPECIAL CHARGE
9 Months Ended
Sep. 30, 2022
Restructuring and Related Activities [Abstract]  
SPECIAL CHARGE SPECIAL CHARGEIn September 2022, the Company decided to exit its HARPOON surgical mitral repair system program. As a result, the Company recorded a charge to its United States segment of $68.4 million, of which $66.8 million was included in "Special Charge" and $1.6 million was included in "Cost of Sales" on the consolidated condensed statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology and other related exit costs. The Company believes that no additional contingent consideration is due and, in September 2022, recorded an $11.7 million contingent consideration gain associated with the exit (see Note 7).